The Pharmaceutical Price Regulation Scheme (PPRS) ensures the NHS has access to good quality branded medicines at reasonable prices, and promotes a healthy, competitive pharmaceutical industry.
In 1994 the Health Committee recommended that the Department of Health introduce greater transparency into the PPRS by publishing an annual report on the scheme. The first report was published in 1996, and there has been one almost every year since.
Published: 01/12/2002
Following the 1999 PPRS agreement, a joint assessment by the Department of Health and the Association of the British Pharmaceutical Industry (ABPI) of the scope, pace of change and practical impact of competition in the supply and use of branded medicines for the NHS took place. The results of this study will be available to both the Government and the pharmaceutical industry in considering the future direction of policy on the PPRS.